Fisher & Paykel Healthcare can’t predict the future

Fisher & Paykel Healthcare can’t predict the future
Chief executive Lewis Gradon told analysts there was a big opportunity ahead but couldn't say when the company would reach it. (Photo: Supplied)
Dan Brunskill
Medical device manufacturer Fisher & Paykel Healthcare is unquestionably in a better position than it was pre-covid, the question everyone is asking is: how much better? It was a question that not even chief executive Lewis Gradon was able to answer when asked by analysts after reporting earnings on Wednesday. The company declined to give earnings guidance for the third straight year, saying it was too hard to predict how much stock customers would want to hold and the possibility of future covid-19 surges.Unable to give guidance,...

More Markets

NZ sharemarket celebrates a near 1% Easter rise
Markets Market close

NZ sharemarket celebrates a near 1% Easter rise

The S&P/NZX 50 Index closed at 12,105.29, up 94.62 points or 0.79%.

Graham Skellern 28 Mar 2024
F&P Healthcare facing $12m bill for product recall
Markets

F&P Healthcare facing $12m bill for product recall

The company will provision the cost in its next full year results.

Staff reporters 28 Mar 2024
Synlait seeking help from major shareholder for $130m debt
Markets

Synlait seeking help from major shareholder for $130m debt

Synlait enters trading halt as it needs more time to come up with cash.